IGF2BP3 and hepatocellular carcinoma: In multiple Lenvatinib-resistant HCC models, increased glycolytic efficiency and lactate accumulation leads to lactylation of insulin like growth factor 2 mRNA binding protein 3 (IGF2BP3) at K76 site.